Overview

A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis

Status:
RECRUITING
Trial end date:
2029-05-01
Target enrollment:
Participant gender:
Summary
The goal of this open-label clinical trial is to evaluate the efficacy of AzaFol-PET/CT in the diagnosis of GCA (giant cell arteritis), to compare AzaFol- with 2-\[18F\]FDG-PET/CT, and to assess the safety and tolerability of AzaFol in subjects with suspicion of GCA. Participants will undergo AzaFol-PET/CT imaging at a single timepoint.
Phase:
PHASE2
Details
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Collaborator:
Paul Scherrer Institut, Center for Proton Therapy